These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26493658)

  • 1. Treatment of Dyslipidemia in Elderly Patients With Coronary Heart Disease: There Are Miles to Go Before We Sleep.
    Toth PP
    J Am Coll Cardiol; 2015 Oct; 66(17):1873-5. PubMed ID: 26493658
    [No Abstract]   [Full Text] [Related]  

  • 2. Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease: A Retrospective Cohort Study in the Medicare Population 2007 to 2011.
    Bittner V; Deng L; Rosenson RS; Taylor B; Glasser SP; Kent ST; Farkouh ME; Muntner P
    J Am Coll Cardiol; 2015 Oct; 66(17):1864-72. PubMed ID: 26493657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time trend analysis and variations in prescribing lipid lowering drugs in general practice.
    Baxter C; Jones R; Corr L
    BMJ; 1998 Oct; 317(7166):1134-5. PubMed ID: 9784452
    [No Abstract]   [Full Text] [Related]  

  • 4. Frequency of lipid-lowering therapy after a coronary event in Helsinki, Finland.
    Strandberg TE; Vanhanen H; Tikkanen MJ
    Am J Cardiol; 1999 Jul; 84(1):95, A8. PubMed ID: 10404860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Countering clinical inertia in lipid management: Expert workshop summary.
    Zullig LL; Egbuonu-Davis L; Trasy A; Oshotse C; Goldstein KM; Bosworth HB
    Am Heart J; 2018 Dec; 206():24-29. PubMed ID: 30290290
    [No Abstract]   [Full Text] [Related]  

  • 6. Around PediHeart: hyperlipidemia.
    McCaffrey F
    Pediatr Cardiol; 2001; 22(1):52. PubMed ID: 11123128
    [No Abstract]   [Full Text] [Related]  

  • 7. Identifying patients at risk for coronary heart disease: treatment implications.
    Shepherd J
    Eur Heart J; 1998 Dec; 19(12):1776-83. PubMed ID: 9886719
    [No Abstract]   [Full Text] [Related]  

  • 8. Temporal trends (1986-1997) in cholesterol level assessment and management practices in patients with acute myocardial infarction: a population-based perspective.
    Yarzebski J; Spencer F; Goldberg RJ; Lessard D; Gore JM
    Arch Intern Med; 2001 Jun; 161(12):1521-8. PubMed ID: 11427100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-hyperlipidemic agents].
    Kinoshita M
    Nihon Rinsho; 2002 May; 60(5):968-74. PubMed ID: 12030001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Heart Protection Study: expanding the boundaries for high-risk coronary disease prevention.
    Farmer JA; Gotto AM
    Am J Cardiol; 2003 Jul; 92(1A):3i-9i. PubMed ID: 12867249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Optimization of cholesterol reduction principles and clinical results of dual inhibition].
    von Hodenberg E
    Internist (Berl); 2005 May; 46 Suppl 1():S18-23. PubMed ID: 15834540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-lowering drug therapy: more knowledge leads to more problems for composers of guidelines.
    Durrington PN; Illingworth DR
    Curr Opin Lipidol; 2000 Aug; 11(4):345-9. PubMed ID: 10945714
    [No Abstract]   [Full Text] [Related]  

  • 13. Rationale, design features, and baseline characteristics: The Heart Institute of Japan-PRoper level of lipid lOwering with Pitavastatin and Ezetimibe in acute coRonary syndrome (HIJ-PROPER).
    Kawada-Watanabe E; Ogawa H; Koyanagi R; Arashi H; Yamaguchi J; Matsui K; Hagiwara N
    J Cardiol; 2017 Mar; 69(3):536-541. PubMed ID: 27349705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Coronary risk in Spain and its treatment with lipid-lowering drugs].
    Maiques Galán A; Villar Alvarez F; Llor Vila C; Torcal Laguna J
    Aten Primaria; 2003 Oct; 32(7):420-2. PubMed ID: 14622555
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of dyslipidemia. Progress in cardiologic practice].
    Cybulska B
    Pol Arch Med Wewn; 2001; 105 Suppl():205-9. PubMed ID: 12412248
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary prevention of coronary heart disease: where do we go from here?
    Gotto AM
    Arch Intern Med; 2001 Apr; 161(7):922-4. PubMed ID: 11295953
    [No Abstract]   [Full Text] [Related]  

  • 17. Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia.
    Nakamura T; Kodama Y; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Kitta Y; Kobayashi T; Mende A; Kugiyama K
    Atherosclerosis; 2007 Aug; 193(2):449-51. PubMed ID: 16997309
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of dyslipidemia in adults with diabetes. American Diabetes Association.
    Diabetes Care; 1998 Jan; 21(1):179-82. PubMed ID: 9538989
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
    Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
    Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with acute coronary syndrome should start a statin while still in hospital.
    Isles CG
    Heart; 2002 Jul; 88(1):5-6. PubMed ID: 12067927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.